FRESENIUS MEDICAL CARE-ADR (FMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:FMS - US3580291066 - ADR
23.82 USD
-0.07 (-0.29%)
23.82 USD
0 (0%)
FMS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of FMS while its profitability can be described as average. FMS is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year FMS was profitable.
FMS had a positive operating cash flow in the past year.
FMS had positive earnings in each of the past 5 years.
Each year in the past 5 years FMS had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 2.33%, FMS perfoms like the industry average, outperforming 58.42% of the companies in the same industry.
Looking at the Return On Equity, with a value of 5.55%, FMS is in the better half of the industry, outperforming 60.40% of the companies in the same industry.
With a Return On Invested Capital value of 3.95%, FMS perfoms like the industry average, outperforming 49.51% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for FMS is significantly below the industry average of 9.58%.
The 3 year average ROIC (3.14%) for FMS is below the current ROIC(3.95%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
Looking at the Profit Margin, with a value of 3.66%, FMS is in the better half of the industry, outperforming 72.28% of the companies in the same industry.
FMS's Profit Margin has declined in the last couple of years.
FMS's Operating Margin of 7.19% is fine compared to the rest of the industry. FMS outperforms 71.29% of its industry peers.
In the last couple of years the Operating Margin of FMS has declined.
FMS has a Gross Margin (25.00%) which is in line with its industry peers.
In the last couple of years the Gross Margin of FMS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FMS is destroying value.
Compared to 1 year ago, FMS has about the same amount of shares outstanding.
Compared to 5 years ago, FMS has less shares outstanding
Compared to 1 year ago, FMS has an improved debt to assets ratio.
2.2 Solvency
FMS has an Altman-Z score of 1.80. This is a bad value and indicates that FMS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.80, FMS is not doing good in the industry: 60.40% of the companies in the same industry are doing better.
FMS has a debt to FCF ratio of 5.97. This is a neutral value as FMS would need 5.97 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.97, FMS is doing good in the industry, outperforming 61.39% of the companies in the same industry.
FMS has a Debt/Equity ratio of 0.73. This is a neutral value indicating FMS is somewhat dependend on debt financing.
FMS has a Debt to Equity ratio (0.73) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 1.8 |
ROIC/WACC0.78
WACC5.06%
2.3 Liquidity
A Current Ratio of 1.36 indicates that FMS should not have too much problems paying its short term obligations.
With a Current ratio value of 1.36, FMS perfoms like the industry average, outperforming 49.51% of the companies in the same industry.
A Quick Ratio of 1.00 indicates that FMS may have some problems paying its short term obligations.
The Quick ratio of FMS (1.00) is worse than 65.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
FMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.77%, which is quite good.
Measured over the past years, FMS shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.43% on average per year.
The Revenue has been growing slightly by 2.10% in the past year.
Measured over the past years, FMS shows a small growth in Revenue. The Revenue has been growing by 2.04% on average per year.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
Based on estimates for the next years, FMS will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.73% on average per year.
Based on estimates for the next years, FMS will show a small growth in Revenue. The Revenue will grow by 4.08% on average per year.
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y13.73%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y4.08%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.83 indicates a reasonable valuation of FMS.
87.13% of the companies in the same industry are more expensive than FMS, based on the Price/Earnings ratio.
FMS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.51.
FMS is valuated reasonably with a Price/Forward Earnings ratio of 9.82.
Based on the Price/Forward Earnings ratio, FMS is valued cheaper than 89.11% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.13. FMS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.83 | ||
| Fwd PE | 9.82 |
4.2 Price Multiples
FMS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. FMS is cheaper than 87.13% of the companies in the same industry.
FMS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. FMS is cheaper than 90.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.78 | ||
| EV/EBITDA | 6.61 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FMS's earnings are expected to grow with 13.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y13.16%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.54%, FMS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 0.60, FMS pays a better dividend. On top of this FMS pays more dividend than 99.01% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, FMS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.54% |
5.2 History
The dividend of FMS has a limited annual growth rate of 0.31%.
FMS has paid a dividend for at least 10 years, which is a reliable track record.
FMS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.31%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
58.83% of the earnings are spent on dividend by FMS. This is a bit on the high side, but may be sustainable.
The dividend of FMS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP58.83%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
23.82
-0.07 (-0.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.88%
Inst Owner Change-1.04%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.98B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts57.93
Price Target27.74 (16.46%)
Short Float %0.29%
Short Ratio2.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.54% |
Yearly Dividend0.7
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-0.94%
PT rev (3m)-7.66%
EPS NQ rev (1m)2.05%
EPS NQ rev (3m)-4.08%
EPS NY rev (1m)2.83%
EPS NY rev (3m)2.91%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)1.16%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.83 | ||
| Fwd PE | 9.82 | ||
| P/S | 0.61 | ||
| P/FCF | 6.78 | ||
| P/OCF | 4.74 | ||
| P/B | 0.92 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.61 |
EPS(TTM)2.2
EY9.24%
EPS(NY)2.43
Fwd EY10.18%
FCF(TTM)3.51
FCFY14.75%
OCF(TTM)5.03
OCFY21.11%
SpS39.33
BVpS25.93
TBVpS-3.78
PEG (NY)0.5
PEG (5Y)N/A
Graham Number35.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROCE | 5.62% | ||
| ROIC | 3.95% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 11.65% | ||
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% | ||
| FCFM | 8.93% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 47.15% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 3.87 | ||
| Cash Conversion | 83.24% | ||
| Profit Quality | 244.33% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 1.8 |
F-Score5
WACC5.06%
ROIC/WACC0.78
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y13.73%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y4.08%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.22%
EBIT Next 3Y29.78%
EBIT Next 5Y18.68%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE-ADR / FMS FAQ
What is the fundamental rating for FMS stock?
ChartMill assigns a fundamental rating of 5 / 10 to FMS.
Can you provide the valuation status for FRESENIUS MEDICAL CARE-ADR?
ChartMill assigns a valuation rating of 8 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.
What is the profitability of FMS stock?
FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 5 / 10.
What is the expected EPS growth for FRESENIUS MEDICAL CARE-ADR (FMS) stock?
The Earnings per Share (EPS) of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to grow by 21.73% in the next year.
Is the dividend of FRESENIUS MEDICAL CARE-ADR sustainable?
The dividend rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 6 / 10 and the dividend payout ratio is 58.83%.